Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

'No crazy stuff in it': Mexico budget keeps expectations in check

Dec 16, 2018

By Dave GrahamMEXICO CITY (Reuters) - Mexico's new leftist government presented a first budget aimed at calming nervous markets while honoring pledges to increase welfare spending, saying it would run a bigger surplus next year once interest payments on debt were excluded.Finance Minister Carlos Urzua presented the budget on Saturday evening, setting out plans to find more money for both the elderly and unemployed youngsters by slimming down several government ministries and through forecasts of higher tax revenues.The budget is a major test of President Andres Manuel Lopez Obrador's economic credibility, which was shaken when he said on Oct. 29...

2018: The year volatility came home to roost

Dec 16, 2018

By Saqib Iqbal AhmedNEW YORK (Reuters) - U.S. stocks are down only slightly for 2018, but that masks a volatile year for investors.Trade-related tensions between the United States and China, weakness in the tech sector, concerns about slowing global growth and jitters about the Federal Reserve marching toward higher interest rates have kept investors on their toes.Daily gyrations for the S&P 500 Index spiked sharply this year and remain near a one-year high.One-month historical volatility - a measure of how much stocks have swung on a daily basis over the course of a month - has risen to 21 percent,...

Executive's arrest, security worries stymie Huawei's reach

Dec 16, 2018

BEIJING — While a Huawei executive faces possible U.S. charges over trade with Iran, the Chinese tech giant's ambition to be a leader in next-generation telecoms is colliding with security worries abroad. Australia and New Zealand have barred Huawei Technologies Ltd. as a supplier for fifth-generation networks. They joined the United States and Taiwan, which limit use of technology from the biggest global supplier of network switching gear. This week, Japan's cybersecurity agency said Huawei and other vendors deemed risky will be off-limits for government purchases. None has released evidence of wrongdoing by Huawei, which denies it is a risk...

Nations agree on global climate pact rules, but they are seen as weak

Dec 16, 2018

By Nina Chestney, Bate Felix and Agnieszka BarteczkoKATOWICE, Poland (Reuters) - Nearly 200 countries overcame political divisions late on Saturday to agree on rules for implementing a landmark global climate deal, but critics say it is not ambitious enough to prevent the dangerous effects of global warming.After two weeks of talks in the Polish city of Katowice, nations finally reached consensus on a more detailed framework for the 2015 Paris Agreement, which aims to limit a rise in average world temperatures to "well below" 2 degrees Celsius (3.6 degrees Fahrenheit) above pre-industrial levels."It is not easy to find agreement on...

China's Xi to address key reform anniversary on Tuesday: Xinhua

Dec 16, 2018

BEIJING (Reuters) - President Xi Jinping will make a major speech on Tuesday to mark the 40th anniversary of China's reform and opening up, state news agency Xinhua reported.Xi will speak at a conference to be held at the Great Hall of the People from 10 a.m. (0200 GMT) on Tuesday, Xinhua said on Sunday. The report was in line with what diplomatic sources had previously told Reuters.Former leader Deng Xiaoping initiated China's historic reform and opening up in 1978, followed by a series of capitalist experiments that lifted much of China out of poverty and turned it into an...

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com